5 µg/ml
Trade Name
Paricalcitol Spectro
Solution for injection
Request Type
New Registration
Drug Type
Generic
Approval Date
SFDA Approved Use
Indicated in adults for the prevention and treatment of secondary hyperparathyroidism in patients with chronic renal failure who are undergoing haemodialysis.